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A bidirectional fluorescent two-hybrid system for
monitoring protein–protein interactions†
Ida Karin Nordgrena and Ali Tavassoli*ab
Two-hybrid systems have been the cornerstone of research into protein–protein interactions, but these
systems typically rely on life/death reporters that put additional selective pressure on the host organism,
and potentially lead to false positives. Here we report a bidirectional fluorescence-based bacterial two-
hybrid system that enables both the association and dissociation of a given protein–protein interaction
to be monitored. The functionality of this system and its compatibility with FACS screening are demon-
strated in the forward and reverse direction using known interacting protein-partners and their cyclic
peptide inhibitors. The reported fluorescent two-hybrid system may be used in the forward direction for
the identification of interacting protein partners, or as a reverse two-hybrid system for the high-
throughput identification of protein–protein interaction inhibitors.
Introduction
Protein–protein interactions regulate the majority of cellular
processes and are significant points of intervention for the
development of therapeutics.1 Various two-hybrid technologies
have been developed,2 with bacterial and yeast two-hybrid
systems (THS)3–7 extensively used to identify, characterize and
monitor interacting proteins.8–15 Each system has its advan-
tages and disadvantages; bacterial THS eliminate the require-
ments for nuclear import and reduce false positives arising
from complex formation and activation of transcription in the
absence of a binding partner, whereas yeast THS allow the use
of protein interactions that require post-translational modifica-
tions. The majority of two-hybrid systems rely on a life/death
phenotype, which puts selective pressure on the host organism,
potentially leading to false positives. This stress may be alle-
viated by a fluorescence reporter, which does not exert survival
pressure on the host organism and therefore should reduce the
number of isolated false positives. Bimolecular fluorescence
complementation (BiFC) assays16,17 provide a viable alternative
for monitoring protein–protein interactions using a fluorescent
reporter,18–20 but these systems also bring potential complica-
tion in their use, as their expression in E. coli has been shown
to be toxic due to the formation of insoluble products.21,22
Additionally, BiFC is not optimally suited to identification of
protein–protein interaction inhibitors, as once assembled, the
fluorescent reporter protein halves do not readily dissipate.
Reverse two-hybrid systems (RTHS)23–25 are used to monitor for
disruption of protein–protein interactions via life/death selec-
tions, and have been extensively used for the discovery of
molecules that inhibit protein–protein interactions.12,15,26,27
We have previously utilized a bacterial RTHS based on l
phage repressor proteins and two essential reporter genes; HIS3
(imidazole glycerol phosphate dehydratase) and KanR (amino-
glycoside 30-phosphotransferase for kanamycin resistance)
inhibit growth on selective media lacking histidine and con-
taining kanamycin.12,15 We have used this bacterial RTHS to
identify and characterize interacting protein pairs,8,11,13 and in
combination with a genetically-encoded cyclic peptide library of
around a hundred million members28 for the rapid identification
of inhibitors of a targeted protein–protein interaction.15,27,29,30
Aiming to eliminate the selective pressure exerted on the bacter-
ial host by the reporter genes (HIS3 and KanR), and to enable
automation of the screening process using fluorescence-activated
cell sorting (FACS), we set out to develop a fluorescence-based
two-hybrid system (FTHS) suitable for the identification of
protein–protein interaction inhibitors. Here we report a bacterial
FTHS that operates in both the forward and reverse direction,
and may be used for the detection of protein–protein inter-
actions, or for the identification of protein–protein interaction
inhibitors.
Materials and methods
Construction of the FTHS reporter strain
The gene encoding tdTomato was amplified from pRSET-td-
Tomato31 with Deep Vent (New England Biolabs) using the
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primers listed in Table S1 (ESI†). The PCR product was ligated
into the integration plasmid pAH15332 via BamHI and EcoRI
restriction endonuclease sites. The resulting plasmid was inte-
grated onto the chromosome of the BW27786 strain of E. coli
using the f80 phage integrase encoded from the CRIM helper
plasmid pAH123, as previously described.32 Plasmids encoding
the targeted proteins (HIF-1a and HIF-1b, or P6 and UEV) as
fusions with the bacteriophage 434 and chimeric P22 DNA
binding domains were constructed in pTHCP14 as previously
described.12,27 The region encoding the targeted fusion pro-
teins was ligated into the integration plasmid pAH68 and
incorporated onto the HK022 binding site on the chromosome
of the above BW27786-derived FTHS reporter strain using a
plasmid encoding the HK022 integrase,13,32 to give the HIF-1
and p6/UEV FTHS. A negative control FTHS encoding the
repressor domains only (434 and P22) was also constructed.
Characterizing the FTHS
The HIF-1 or p6/UEV FTHS was cultured overnight at 37 1C with
gentamycin (12.5 mg mL1) and ampicillin (50 mg mL1), and
subcultured into 1 mL of M9 media containing the same levels
of antibiotics as the overnight culture, and varying concentra-
tions of IPTG (0–100 mM). These mixtures were incubated with
shaking for 24 hours at 30 1C, followed by 10-fold dilution with
M9 media. Fluorescence of the resulting mixtures was assessed
in black 96 well half-area microplates (Greiner Bio-One, USA),
with excitation at 514 nm (10 nm bandwidth) and emission
measured between 550 and 650 nm (5 nm bandwidth) using a
Tecan Safire2 plate reader.
Isolation of protein–protein interaction inhibitors by FACS
FACS readings and sorting were carried out using a Becton
Dickinson FACSort mechanical cell sorter instrument with a
488 nm laser equipped with an orange (FL-2, 600  30) filter,
and Becton Dickinson CellQuest acquisition software. Analysis
of FACS data was carried out using Windows Multiple Docu-
ment Interface software (WinMDI). Cultures were prepared for
measurements and sorting as above in M9 media. The number
of events per second was kept to below 1000 by diluting the
culture as required with M9 media to minimize inaccuracies in
the measurements. SICLOPPS plasmids (with a p15A origin of
replication, which results in B10 copies of SICLOPPS plasmid
per cell)28 encoding cyclic peptide inhibitors of the p6/UEV
(cyclo-SGWIYWNV),27 and HIF-1 (cyclo-CLLFVY)30 were trans-
formed into their corresponding FTHS. A negative control
SICLOPPS plasmid encoding cyclo-CAAAAA was transformed
into both FTHS. The resulting cells were grown overnight in
LB media supplemented with ampicillin (50 mg mL1), genta-
mycin (12.5 mg mL1) and chloramphenicol (35 mg mL1), and
subcultured into 1 mL of M9 media supplemented with IPTG
(25 or 50 mM), L-arabinose (6.5 mM), ampicillin (50 mg mL1),
gentamycin (12.5 mg mL1) and chloramphenicol (35 mg mL1).
These cultures were incubated with shaking for 24 hours at
30 1C and mixed in a 1 : 1 (v/v) ratio with their equivalent FTHS
with a plasmid encoding cyclo-CAAAAA and sorted by FACS. The
output of each gate was collected for 2 minutes into 2 LB
media (without antibiotics) and recovered by incubation
with shaking at 37 1C for 1 hour 30 minutes. Ampicillin
(50 mg mL1), gentamycin (12.5 mg mL1) and chloramphenicol
(35 mg mL1) were added to the recovery mixtures and these
were incubated with shaking overnight at 37 1C. The SICLOPPS
plasmids from these cultures were isolated (plasmid mini prep
kit, QIAGEN) and analyzed by restriction digestion with PstI
and ScaI restriction endonucleases (New England Biolabs).
Results
Design and construction of the FTHS
Our FTHS monitors protein–protein interactions by utilizing
repressor domains from the bacteriophage regulatory system,33
with the targeted proteins expressed as hybrid fusions of a 434,
and chimeric 434.P22 repressor complex.10 The reporter con-
struct contains the chimeric 434.P22 operators followed by the
red fluorescent protein tdTomato31 (Fig. S1, ESI†), chosen from
a series of fluorescent proteins for its fast maturation time and
high visibility over E. coli autofluorescence (Fig. S2, ESI†).34
The tdTomato reporter construct was integrated onto the
F80 phage-attachment site on the chromosome of E. coli, using
the F80 phage integrase.32 In the absence of a repressor complex,
the fluorescence emission of the constitutively expressed tdTomato
at 581 nm was readily detected in the FTHS strain using a
fluorescence micro-plate reader (Fig. 1 and Fig. S3, ESI†). Expres-
sion of the targeted interacting proteins fused to the 434 and P22
Fig. 1 Monitoring protein–protein interactions with the FTHS (A) the
tdTomato reporter construct integrated onto the chromosome of the
E. coli host. (B) IPTG induces the expression of the targeted proteins (X and
Y) and their interaction reconstitutes the functional repressor that prevents
the transcription of the fluorescent reporter gene downstream. (C) In the
presence of an inhibitor (purple circle, SICLOPPS cyclic peptide induced
by arabinose), or if the targeted proteins do not interact, the 434.P22
repressor is not functional, allowing transcription of the fluorescent
reporter gene tdTomato.
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repressor domains (induced by IPTG in the FTHS strain) would be
expected to lead to the formation of a functional 434.P22 repressor
that binds the chimeric 434.P22 operator upstream of tdTomato,
and lead to the shutdown of the fluorescence signal (Fig. 1B), in an
IPTG-dependent manner. If the targeted proteins do not interact,
or in the presence of a protein–protein interaction inhibitor, the
434.P22 repressor will not form, allowing expression of the red
fluorescence reporter gene (Fig. 1C).
Assessing the FTHS for identification of protein–protein
interactions
To assess the function of the FTHS in the forward direction, we
monitored the interaction of the a and b subunits of hypoxia
inducible factor-1 (HIF-1), the primary sensor for cellular
hypoxia,35 and p6 subunit of HIV Gag protein and the UEV
domain of the human protein TSG101,27 an essential inter-
action for the budding of HIV from an infected host cell. These
proteins were chosen as we have previously demonstrated their
interaction within a bacterial THS,27,30 and because they repre-
sent two separate classes of protein–protein interactions; the
HIF-1a/HIF-1b complex is formed by a large, multi-domain
interaction interface,36–38 whereas p6 utilizes a tetrapeptide
(PTAP) motif to bind into a groove in UEV.39 The above protein
pairs were cloned into a vector that encodes the bacteriophage
434 repressor DNA binding domain, and a chimeric P22 variant
of 434 (pTHCP14).12 Protein expression from this plasmid is
regulated by IPTG via a tac promoter and a lacIq repressor.
Increasing IPTG levels would therefore be expected to increase
fusion protein levels and lead to a reduction in fluorescence.
The target proteins were initially expressed in the FTHS from
plasmid (pTHCP14); however, background expression (in the
absence of IPTG) from the multiple plasmid copies in the cell
was found to be sufficient to inhibit the fluorescence signal. To
reduce the copy number, the constructs expressing the p6/UEV,
HIF-1a/HIF-1b fusion proteins, and a control plasmid expressing
the P22/434 repressors alone, were cloned into the chromo-
somal integration vector pAH68 and incorporated onto the
chromosome of the bacterial FTHS host, via the HK022 phage
attachment site.32 The ability of the FTHS to identify protein–
protein interactions was assessed by measuring the IPTG-
depended reduction in fluorescence; in the p6/UEV and HIF-1
FTHS, increased IPTG would be expected to result in upregu-
lated expression of the fusion proteins, which dimerize to
form a functional repressor and inhibit tdTomato expression
(Fig. 1B). The P22/434 repressor domains alone do not interact,
thus the fluorescence of the control strain expressing the blank
repressors alone was not affected by increasing IPTG levels
(Fig. 2A and D). In contrast, the p6/UEV (Fig. 2B and D) and
HIF-1 (Fig. 2C and D) FTHS showed IPTG-dependent repression
of tdTomato fluorescence, indicating the formation of a func-
tional repressor capable of inhibiting the expression of tdTomato
in each FTHS.
Fig. 2 IPTG-dependent repression of tdTomato fluorescence in FTHS (excitation at 514 nm). (A) The negative control FTHS strain expressing blank 434
and P22 repressors. (B) The P6/UEV FTHS. (C) The HIF-1 FTHS. (D) Relative change in fluorescence at 581 nm upon increasing IPTG levels for the control,
p6/UEV and HIF-1 FTHS.
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Identification of protein–protein interaction inhibitors
We next sought to determine if our FTHS could be used to
screen for inhibitors of a given protein–protein interaction. We
used our previously reported27,30 cyclic peptide inhibitors of the
p6/UEV and HIF-1a/HIF-1b protein–protein interactions in the
p6/UEV FTHS and HIF-1 FTHS. These compounds were identi-
fied from genetically encoded SICLOPPS (split-intein circular
ligation of peptides and proteins) libraries;28,40 the compound
libraries are plasmid-encoded as SICLOPPS inteins that splices
in E. coli to give cyclic peptides.
The optimal filter for separation of cells with repressed
tdTomato expression from those that express tdTomato was
identified as that filtering for orange fluorescence (FL-2) at
600  30 nm (Fig. S4, ESI†). A significant reduction in host size
has been observed with DsRed expression in E. coli, a result
of its aggregation in the cytoplasm and subsequent toxicity.22
To assess if the expression of tdTomato, or the repressor
proteins results in a similar eﬀect in our FTHS, we assessed
the forward scatter (FSC) of the control FTHS (expressing
tdTomato) and the p6/UEV and HIF-1 FTHS (repressed tdTomato
expression). We did not observe significant diﬀerence in FSC
in these systems (Fig. S5, ESI†), indicating that tdTomato
expression in the FTHS is not significantly aﬀecting host
viability.
The SICLOPPS plasmid corresponding to our HIF-1 dimer-
ization inhibitor (cyclo-CLLFVY)30 was transformed into the
HIF-1 FTHS, and the plasmid encoding our p6/UEV dimeriza-
tion inhibitor (cyclo-SGWIYWNV)27 was transformed into the
p6/UEV strain. A SICLOPPS plasmid encoding cyclo-CAAAAA
was constructed and transformed into the above FTHS as a
negative control (the sequence was confirmed to not disrupt
either protein–protein interaction using the conventional HIF-1
and p6/UEV RTHS). Inhibition of the targeted protein–protein
interaction would be expected to restore tdTomato fluorescence
to the host strain (Fig. 1C), whilst strains expressing the control
peptide (cyclo-CAAAAA) would contain a functional repressor
that inhibits expression of the fluorescent reporter (Fig. 1B).
A series of trial FACS separations were carried out for the p6/UEV
(Fig. 3A) and HIF-1 (Fig. 3B) FTHS, attempting to retrieve the
plasmid encoding the inhibitor peptides from the negative
control using the tdTomato reporter signal (Fig. 3C for p6/UEV
FTHS and Fig. 3D for HIF-1 FTHS). Cells showing the lowest and
highest tdTomato fluorescence were collected from gates M1
and M2 respectively (Fig. 3C and D); plasmids were isolated from
each population and analyzed by restriction digestion. The
plasmid encoding the negative control cyclic peptide contains
a PstI restriction site (within the region encoding the cyclo-CAAAAA
peptide), whereas the plasmids encoding cyclo-CLLFVY and
cyclo-SGWIYWNV do not; all three plasmids contain a ScaI
restriction site in their backbone. Restriction digestion with
PstI and ScaI of the SICLOPPS plasmid encoding cyclo-CLLFVY
therefore yields a 3939 bp fragment (lane 2, Fig. 3E), while the
plasmid encoding cyclo-SGWIYWNV yields a 3945 bp fragment
(lane 2, Fig. 3F), whereas the negative control plasmid (encoding
CAAAAA) yields two fragments at 1462 bp and 2477 bp (lane 3,
Fig. 3E and F). Restriction digestion of the plasmids isolated
from the population of p6/UEV FTHS expressing tdTomato
(corresponding to disruption of the p6/UEV interaction) from
gate M2 (Fig. 3C) showed one band, corresponding to the
plasmid encoding cyclo-SGWIYWNV (lane 6, Fig. 3E), thus indi-
cating that the p6/UEV FTHS can be used for the identification of
inhibitors of this protein–protein interaction. Similar results
were obtained with plasmids from the HIF-1 FTHS isolated from
gate M2 (Fig. 3D), showing one band corresponding to the
plasmid encoding cyclo-CLLFVY (lane 6, Fig. 3F), again indicat-
ing that the HIF-1 FTHS may be used for the identification of
HIF-1 inhibitors. Whilst the plasmids encoding the protein–
protein interaction inhibitors were readily isolated from the
Fig. 3 Trial selection of cyclic peptide protein–protein interaction inhi-
bitors. (A) Density plot of the mixture of the p6/UEV inhibitor and control in
the p6/UEV FTHS. (B) Density plot of the mixture of the HIF-1 inhibitor and
control in the HIF-1 FTHS. (C) Histogram plot of inhibited p6/UEV FTHS,
negative control FTHS, and trial separation; M1 and M2 represent the gates
used for the separation. (D) Histogram plot of inhibited HIF-1 FTHS,
negative control FTHS, and trial separation; M1 and M2 represent the gates
used for the separation. (E) Restriction analysis of the separation of a
mixture of plasmids encoding a p6/UEV inhibitor from a control plasmid.
Lane 1 is ladder, lane 2 is restriction digestion of the plasmid encoding
inhibitor, lane 3 is restriction digestion of a plasmid encoding control, lane 4
is restriction digestion of a mixture of plasmids encoding inhibitor and
control, lane 5 is restriction digestion of plasmids from cells isolated by FACS
from gate M1 in 3C, lane 6 is restriction digestion of plasmids from cells
isolated by FACS from gate M2 in 3C. (F) Restriction analysis of the
separation of a mixture of plasmids encoding a HIF-1 inhibitor from a
control plasmid. Lane 1 is ladder, lane 2 is restriction digestion of a plasmid
encoding inhibitor, lane 3 is restriction digestion of a plasmid encoding
control, lane 4 is restriction digestion of a mixture of plasmids encoding
inhibitor and control, lane 5 is restriction digestion of plasmids from cells
isolated by FACS from gate M1 in 3D, lane 6 is restriction digestion of
plasmids from cells isolated by FACS from gate M2 in 3D.
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inactive control using our FTHS, the opposite selection was not
possible as plasmids encoding both the active and inactive
peptides were present (lane 5, Fig. 3E and F) in the repressed
population of both FTHS (not expressing tdTomato) isolated
from gate M1 (Fig. 3C and D). The SICLOPPS construct is
arabinose-induced, thus the inability to isolate inactive com-
pounds may be due to the fact that arabinose induction is
irregular and thus a portion of the SICLOPPS plasmid popula-
tion will be unevenly induced.41 The FTHSmay therefore be used
for the identification of inhibitors of a given protein–protein
interaction, but not as a negative screen (i.e. for compounds that
do not affect a given protein–protein interaction); further experi-
ments are necessary to probe the roots of this limitation.
Discussion
Two-hybrid technologies continue to expand and evolve, ser-
ving as a critical tool for deciphering and understanding
protein interaction networks, as well as providing a platform
for the identification of protein–protein interaction inhibitors.2
The FTHS detailed here operates in both the forward and
reverse direction, and enables high throughput probing of
protein–protein interactions without placing the host strain
under life/death selective pressure. In the forward direction, the
system may be used for the high-throughput identification of
protein–protein interactions, for example assessing a cDNA
library for binding partners of a given protein. The system
was also demonstrated to function in the reverse direction for
the identification of protein–protein interaction inhibitors; we
illustrated this concept using SICLOPPS inhibitors, but it
should be noted that any genetically encoded library could be
used in conjunction with the reported FTHS.
Alternatively, small molecule libraries may be screened for
inhibitors of a given protein–protein interaction using the
reported FTHS in a 96-well plate format. This approach would
have the advantage of assessing membrane permeability of the
potential inhibitor at the same time; compounds that do not
cross the host’s membrane will not inhibit the targeted inter-
action. Additionally, compounds that are toxic to the host
would result in a decrease or loss of fluorescence, and so would
not be isolated. It should be noted that the performance of the
FTHS would vary to some degree for each protein–protein
interaction examined, depending on the affinity of the targeted
interacting proteins and the ability of the chosen library to
disrupt them; thus functional parameters should be estab-
lished for every constructed FTHS. We are currently using the
FTHS reported here for the high-throughput identification of
protein–protein interaction inhibitors.
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